This is a routine tax-withholding sale, not a discretionary insider disposition. No signal of management's view on valuation. Monitor for any subsequent discretionary Form 4 filings by Neeleman or other insiders.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20- T+0 · Oct 9 $92.61entry
- T+1 · 5w ago −0.63%α −0.57% · $92.03
- T+5 · 5w ago −0.63%α +1.34% · $92.03
- T+20 · 11d ago +11.90%α +17.46% · $103.63
- T+26 · todayOpen
- T+60 · in 7w Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Stephen Neeleman, an officer and director of HealthEquity, filed a Form 144 notice to sell 1,095 shares of common stock valued at approximately $99,815. The shares were acquired through restricted stock vesting between 2023 and 2025. The filing states the sale is a mandatory 'sell to cover' transaction for tax withholding obligations, not a discretionary trade.
Key Facts
- Insider Stephen Neeleman (Officer, Director) filed Form 144 to sell 1,095 shares
- Estimated proceeds: ~$99,815 based on recent sale price of ~$91.16/share
- Shares acquired via restricted stock vesting on 03/29/2023 (410 shares), 03/27/2024 (300 shares), and 04/02/2025 (385 shares)
- Filing explicitly states sale is a mandatory 'sell to cover' transaction for tax withholding, not a discretionary trade
- Proposed sale date: 10/06/2026; filing date: 10/08/2026
Financial Impact
~$99,815 in proceeds from 1,095 shares sold to cover tax withholding
Risk Factors
- Form 144 is an intent to sell, the transaction may not be completed
- Multiple prior restricted stock vestings suggest ongoing equity compensation; future mandatory sales may recur
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001614838-26-000022 |
| Document: 0001614838-26-000022-index.html | 0001614838-26-000022 |
| Document: 0001614838-26-000022.txt | 0001614838-26-000022 |
Track record
20 reports on HQY
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 3, 202613d ago Press Release Neutral 2/10 Entry $108.84 Now $104.58 −3.91% settles Dec 3
- Oct 27, 202620d ago Institutional Cluster Neutral 3/10 Entry $100.88 Now $104.58 +3.67% settles Nov 24
- Oct 19, 202628d ago Insider Cluster Neutral 2/10 Entry $96.60 Now $104.58 +8.26% settles Nov 17
- Oct 9, 20265w ago 8-K Neutral 2/10 Entry $92.03 to $102.11 Now $104.58 +13.64% ▲ +10.95% +14.22% vs SPY
- Oct 9, 20265w ago SC 13G/A Neutral 3/10 Entry $92.61 to $103.63 Now $104.58 +12.93% ▲ +11.90% +17.46% vs SPY
- Oct 8, 20265w ago 144 Neutral 2/10 Entry $92.61 to $103.63 Now $104.58 +12.93% ▲ +11.90% +17.46% vs SPY
- Oct 8, 20265w ago 144 Neutral 2/10 Entry $92.61 to $103.63 Now $104.58 +12.93% ▲ +11.90% +17.46% vs SPY
- Oct 8, 20265w ago 144 Neutral 2/10 Viewing Entry $92.61 to $103.63 Now $104.58 +12.93% ▲ +11.90% +17.46% vs SPY
- Oct 8, 20265w ago 144 Neutral 2/10 Entry $92.61 to $103.63 Now $104.58 +12.93% ▲ +11.90% +17.46% vs SPY
- Oct 8, 20265w ago 144 Neutral 2/10 Entry $92.61 to $103.63 Now $104.58 +12.93% ▲ +11.90% +17.46% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers